Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,028 | 386 | 99.0% |
| Education | $82.62 | 4 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,066 | 23 | $0 (2024) |
| ABBVIE INC. | $1,046 | 43 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $957.91 | 63 | $0 (2024) |
| Lundbeck LLC | $779.96 | 60 | $0 (2023) |
| Allergan, Inc. | $586.76 | 38 | $0 (2021) |
| Neos Therapeutics, LP | $546.74 | 36 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $415.94 | 19 | $0 (2024) |
| ITI, Inc. | $408.15 | 12 | $0 (2023) |
| Corium, LLC | $387.42 | 16 | $0 (2024) |
| Axsome Therapeutics, Inc. | $344.34 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $881.78 | 35 | Axsome Therapeutics, Inc. ($180.56) |
| 2023 | $1,576 | 61 | ABBVIE INC. ($504.67) |
| 2022 | $1,256 | 50 | ABBVIE INC. ($271.47) |
| 2021 | $1,008 | 62 | Takeda Pharmaceuticals U.S.A., Inc. ($255.41) |
| 2020 | $504.00 | 26 | Allergan, Inc. ($217.04) |
| 2019 | $1,485 | 66 | Takeda Pharmaceuticals U.S.A., Inc. ($297.46) |
| 2018 | $610.13 | 52 | Lundbeck LLC ($140.37) |
| 2017 | $789.90 | 38 | Otsuka America Pharmaceutical, Inc. ($250.00) |
All Payment Transactions
390 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/17/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $16.68 | General |
| Category: ADHD | ||||||
| 09/10/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: SCHIZOPHRENIA | ||||||
| 08/22/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $18.34 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 07/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.09 | General |
| Category: NEUROSCIENCE | ||||||
| 07/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 06/18/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: ADHD | ||||||
| 06/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $124.54 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $18.99 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 05/23/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/21/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $13.64 | General |
| Category: ADHD | ||||||
| 05/10/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 04/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: PSYCHIATRY | ||||||
| 04/23/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $18.08 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 04/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Neuropsychiatry | ||||||
| 04/16/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 04/09/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: ADHD | ||||||
| 04/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: NEUROSCIENCE | ||||||
| 03/26/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Psychology/Psychiatric | ||||||
| 03/19/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: ADHD | ||||||
| 03/14/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Neurology | ||||||
| 03/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: CNS Stimulant for ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 57 | 193 | $23,785 | $13,030 |
| 2022 | 2 | 46 | 196 | $24,045 | $13,514 |
| 2021 | 2 | 49 | 164 | $18,730 | $11,996 |
| 2020 | 2 | 47 | 172 | $19,330 | $10,534 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 98 | $16,660 | $8,454 | 50.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 28 | 95 | $7,125 | $4,576 | 64.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 101 | $17,000 | $8,712 | 51.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 23 | 95 | $7,045 | $4,802 | 68.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 25 | 80 | $12,800 | $7,498 | 58.6% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 24 | 84 | $5,930 | $4,498 | 75.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 24 | 81 | $12,960 | $5,854 | 45.2% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 23 | 91 | $6,370 | $4,681 | 73.5% |
About Dr. Gregory Narron, MD
Dr. Gregory Narron, MD is a Psychiatry healthcare provider based in Asheville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043321151.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Narron, MD has received a total of $8,111 in payments from pharmaceutical and medical device companies, with $881.78 received in 2024. These payments were reported across 390 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($8,028).
As a Medicare-enrolled provider, Narron has provided services to 199 Medicare beneficiaries, totaling 725 services with total Medicare billing of $49,074. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Asheville, NC
- Active Since 08/31/2006
- Last Updated 08/04/2022
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1043321151
Products in Payments
- VRAYLAR (Drug) $1,633
- REXULTI (Drug) $1,355
- Adzenys XR-ODT (Drug) $524.88
- TRINTELLIX (Drug) $524.51
- Trintellix (Drug) $452.13
- CAPLYTA (Drug) $443.80
- QELBREE (Drug) $370.47
- Auvelity (Drug) $344.34
- NEUROSTAR TMS THERAPY (Device) $246.79
- BRINTELLIX (Drug) $245.15
- AZSTARYS (Drug) $202.45
- Azstarys (Drug) $184.97
- VYVANSE (Drug) $160.99
- LATUDA (Drug) $140.16
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $137.88
- ABILIFY MAINTENA (Drug) $136.25
- Dyanavel XR (Drug) $132.03
- Xelstrym (Drug) $125.34
- HETLIOZ (Drug) $93.10
- MYDAYIS (Drug) $90.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Asheville
Dr. Scott Emerson, Do, DO
Psychiatry — Payments: $27,006
Dr. Stephen Buie, M.d, M.D
Psychiatry — Payments: $5,987
Marisa Isbell, Pa, PA
Psychiatry — Payments: $5,556
Dr. Ricardo Bierrenbach Decastro, M.d, M.D
Psychiatry — Payments: $5,123
Michael Murray, Do-Phd, DO-PHD
Psychiatry — Payments: $4,023
Lawrence Jones, M.d, M.D
Psychiatry — Payments: $3,745